Drug Details
Nintedanib (Ofev®): Nintedanib is an anti-fibrotic drug that is approved to treat idiopathic pulmonary fibrosis in the United States, Europe, and Australia. In clinical trials, nintedanib has been shown to slow the decline in lung function in mild-to-moderate idiopathic pulmonary fibrosis. It is taken by mouth twice a day.
More Information
